跳至主要内容
临床试验/ACTRN12623000586617
ACTRN12623000586617进行中(未招募)Unknown

An Investigation into the Clinical Performance of the Medacta Masterloc Stem in patients undergoing Total Hip Replacement Procedures

Medacta Australia Pty Ltd0 个研究点目标入组 105 人开始时间: 2023年5月30日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
入组人数
105

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
All

入选标准

  • Patients with symptomatic arthritis who are candidates for a primary total hip replacement with an uncemented femoral stem as determined jointly by the surgeon and the patient.
  • Patients able to give informed consent
  • Patients who understand the conditions of the study and are willing to participate for the length of the prescribed follow-up

排除标准

  • Patients who have had a previous total hip replacement or hip fusion of the affected hip
  • Pregnant women or those seeking to become pregnant
  • Patients with a history of active infection
  • Patients who are a prisoner, currently being treated for a psychiatric disorder, senile dementia, Alzheimer’s disease, or known alcohol or substance abuse
  • Patients who are immunologically suppressed

研究者

相似试验